Last reviewed · How we verify
NCT02751645
Safety and Efficacy of Acute Normovolemic Hemodilution in Pediatric Cardiac Surgery Patients
NA trial testing Acute Normovolemic hemodilution in Cardiac Defect in 24 participants. Status unknown.
31 December 2019
Quick facts
| Lead sponsor | Oregon Health and Science University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 24 |
| Start date | 30 June 2016 |
| Primary completion | 31 December 2019 |
| Estimated completion | 31 May 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Acute Normovolemic hemodilution
Conditions studied
- Cardiac Defect — all drugs for Cardiac Defect →
Sponsor
Oregon Health and Science University
Who can join
Adults 6 Months to 3, any sex, with Cardiac Defect. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The investigators primary objective is to determine if acute normovolemic hemodilution (ANH) for pediatric cardiac surgical patients decreases the volume of blood products transfused during surgery and the immediate post-operative period as compared to usual care. This study will enroll 24 pediatric heart surgery patients, aged 6 months to 3 years old undergoing either ANH prior to initiating cardiopulmonary bypass or the standard of care procedures for the use of cardiopulmonary bypass.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Red blood cell transfusion management for people undergoing cardiac surgery for congenital heart disease.
Wilkinson KL, Kimber C, Allana A, Dorée C, et al · · 2025 · cited 1× · PMID 40105353 · DOI 10.1002/14651858.cd009752.pub3
Verify or expand the search:
- PubMed search for NCT02751645
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Oregon Health and Science University trials
Trials by the same sponsor.
- NCT07431970 — Assessing Construction Execution Under Sleep Impairment · NA · not yet recruiting
- NCT07309757 — Maternal Outcomes With Methamphetamine Use and Cardiac Assessment for Rural Dissemination (MOM CARD) · not yet recruiting
- NCT07282639 — App-Based Certified Diabetes Education Therapy (AB-CDE) · NA · not yet recruiting
- NCT07322588 — Reentry Incentives and Support for Engagement With Contingency Management · NA · not yet recruiting
- NCT07220590 — Implementing Powered Mobility in Early Childhood Settings for Children With Cerebral Palsy · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02751645 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Oregon Health and Science University
- Last refreshed: 16 May 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02751645.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing